Literature DB >> 11027342

RelB nuclear translocation regulates B cell MHC molecule, CD40 expression, and antigen-presenting cell function.

B J O'Sullivan1, K P MacDonald, A R Pettit, R Thomas.   

Abstract

Mice with targeted RelB mutations demonstrated an essential role for RelB in immune responses and in myeloid dendritic cell differentiation. Human studies suggested a more global transcriptional role in antigen presentation. Burkitt lymphoma cell lines were used as a model to examine the role of RelB in antigen presentation. After transient transfection of BJAB with RelB, strong nuclear expression of RelB-p50 heterodimers was associated with increased APC function and expression of CD40 and MHC class I. Antisense RelB in DG75 reduced antigen-presenting capacity and CD40-mediated up-regulation of MHC molecules. The data indicate that RelB transcriptional activity directly affects antigen presentation and CD40 synthesis. Stimulation of RelB transcriptional activity may provide a positive feedback loop for facilitating productive APC/T cell interactions.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11027342      PMCID: PMC17215          DOI: 10.1073/pnas.97.21.11421

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

1.  RelB regulation of chemokine expression modulates local inflammation.

Authors:  Y Xia; M E Pauza; L Feng; D Lo
Journal:  Am J Pathol       Date:  1997-08       Impact factor: 4.307

2.  Nuclear localization of RelB is associated with effective antigen-presenting cell function.

Authors:  A R Pettit; C Quinn; K P MacDonald; L L Cavanagh; G Thomas; W Townsend; M Handel; R Thomas
Journal:  J Immunol       Date:  1997-10-15       Impact factor: 5.422

3.  Thymic cortical epithelium is sufficient for the development of mature T cells in relB-deficient mice.

Authors:  J DeKoning; L DiMolfetto; C Reilly; Q Wei; W L Havran; D Lo
Journal:  J Immunol       Date:  1997-03-15       Impact factor: 5.422

Review 4.  Origin, maturation and antigen presenting function of dendritic cells.

Authors:  M Cella; F Sallusto; A Lanzavecchia
Journal:  Curr Opin Immunol       Date:  1997-02       Impact factor: 7.486

5.  Multifocal defects in immune responses in RelB-deficient mice.

Authors:  F Weih; G Warr; H Yang; R Bravo
Journal:  J Immunol       Date:  1997-06-01       Impact factor: 5.422

6.  Dendritic-like cells from relB mutant mice.

Authors:  L DiMolfetto; C Reilly; Q Wei; D Lo
Journal:  Adv Exp Med Biol       Date:  1997       Impact factor: 2.622

7.  CD40, but not lipopolysaccharide and anti-IgM stimulation of primary B lymphocytes, leads to a persistent nuclear accumulation of RelB.

Authors:  M Neumann; G Wohlleben; S Chuvpilo; B Kistler; T Wirth; E Serfling; A Schimpl
Journal:  J Immunol       Date:  1996-12-01       Impact factor: 5.422

8.  Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression.

Authors:  F Köntgen; R J Grumont; A Strasser; D Metcalf; R Li; D Tarlinton; S Gerondakis
Journal:  Genes Dev       Date:  1995-08-15       Impact factor: 11.361

9.  Characterization of elements determining the dimerization properties of RelB and p50.

Authors:  R P Ryseck; J Novotny; R Bravo
Journal:  Mol Cell Biol       Date:  1995-06       Impact factor: 4.272

10.  p50-NF-kappaB complexes partially compensate for the absence of RelB: severely increased pathology in p50(-/-)relB(-/-) double-knockout mice.

Authors:  F Weih; S K Durham; D S Barton; W C Sha; D Baltimore; R Bravo
Journal:  J Exp Med       Date:  1997-04-07       Impact factor: 14.307

View more
  17 in total

1.  RelB nuclear translocation mediated by C-terminal activator regions of Epstein-Barr virus-encoded latent membrane protein 1 and its effect on antigen-presenting function in B cells.

Authors:  Saparna Pai; Brendan J O'Sullivan; Leanne Cooper; Ranjeny Thomas; Rajiv Khanna
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

2.  Regulation of RelB expression during the initiation of dendritic cell differentiation.

Authors:  Pedro J Cejas; Louise M Carlson; Despina Kolonias; Jian Zhang; Inna Lindner; Daniel D Billadeau; Lawrence H Boise; Kelvin P Lee
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

Review 3.  NF-κB signaling pathway and its potential as a target for therapy in lymphoid neoplasms.

Authors:  Li Yu; Ling Li; L Jeffrey Medeiros; Ken H Young
Journal:  Blood Rev       Date:  2016-10-13       Impact factor: 8.250

Review 4.  Regulation of NF-κB by TNF family cytokines.

Authors:  Matthew S Hayden; Sankar Ghosh
Journal:  Semin Immunol       Date:  2014-06-21       Impact factor: 11.130

5.  PD-L1- and calcitriol-dependent liposomal antigen-specific regulation of systemic inflammatory autoimmune disease.

Authors:  Ryan Galea; Hendrik J Nel; Meghna Talekar; Xiao Liu; Joshua D Ooi; Megan Huynh; Sara Hadjigol; Kate J Robson; Yi Tian Ting; Suzanne Cole; Karyn Cochlin; Shannon Hitchcock; Bijun Zeng; Suman Yekollu; Martine Boks; Natalie Goh; Helen Roberts; Jamie Rossjohn; Hugh H Reid; Ben J Boyd; Ravi Malaviya; David J Shealy; Daniel G Baker; Loui Madakamutil; A Richard Kitching; Brendan J O'Sullivan; Ranjeny Thomas
Journal:  JCI Insight       Date:  2019-09-19

6.  Protein kinase C blockade inhibits differentiation of myeloid blasts into dendritic cells by calcium ionophore A23187.

Authors:  Qian Li; Howard Ozer; Inna Lindner; Kelvin P Lee; Mohamed A Kharfan-Dabaja
Journal:  Int J Hematol       Date:  2005-02       Impact factor: 2.490

7.  Identification of human metapneumovirus-induced gene networks in airway epithelial cells by microarray analysis.

Authors:  X Bao; M Sinha; T Liu; C Hong; B A Luxon; R P Garofalo; A Casola
Journal:  Virology       Date:  2008-01-29       Impact factor: 3.616

8.  Inhibition of NF-kappa B during human dendritic cell differentiation generates anergy and regulatory T-cell activity for one but not two human leukocyte antigen DR mismatches.

Authors:  Ana Hernandez; Melissa Burger; Bonnie B Blomberg; William A Ross; Jeffrey J Gaynor; Inna Lindner; Robert Cirocco; James M Mathew; Manuel Carreno; Yidi Jin; Kelvin P Lee; Violet Esquenazi; Joshua Miller
Journal:  Hum Immunol       Date:  2007-07-02       Impact factor: 2.850

Review 9.  Dendritic cells and the promise of antigen-specific therapy in rheumatoid arthritis.

Authors:  Ranjeny Thomas
Journal:  Arthritis Res Ther       Date:  2013-02-04       Impact factor: 5.156

10.  Dexamethasone prevents interleukin-1beta-induced nuclear factor-kappaB activation by upregulating IkappaB-alpha synthesis, in lymphoblastic cells.

Authors:  M Castro-Caldas; A F Mendes; A P Carvalho; C B Duarte; M C Lopes
Journal:  Mediators Inflamm       Date:  2003-02       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.